Posted: 07/06/2025 03:27 am
Health Catalyst, Inc., a prominent provider of data and analytics technology and services to healthcare organizations, is making strategic waves in the industry amidst its evolving compensation structures. Recent financial figures reveal insightful trends regarding its top executives' remuneration, illuminating the company's internal strategies as it navigates a competitive marketplace.
In 2024, Linda Llewelyn, Chief People Officer at Health Catalyst, earned a total compensation of $1,409,780, primarily attributed to a base salary of $373,333 and substantial stock awards amounting to $924,666. Notably, Llewelyn did not receive a bonus, emphasizing the company’s dependency on stock incentives rather than direct cash payouts for executive compensation^1. These compensation practices align with a broader industry trend where stock awards are leveraged to align executives' interests with shareholders and company growth.
Contrastingly, in 2023, Bryan Hunt, who served as the Chief Financial Officer, received a significantly higher total compensation package at $2,385,310. This included a base salary of $315,000 and stock awards nearing $2 million. The substantial stock award component signifies the importance placed on equity incentives in executive compensation, potentially designed to drive long-term strategic growth^2.
Earlier records from 2020 reveal Daniel Orenstein, then General Counsel, earning $1,710,044, with the predominant portion again stemming from stock awards. These figures mirror compensation patterns seen elsewhere in the company, highlighting an investment-centric approach^3.
Health Catalyst's executive compensation strategies coincide with notable achievements in the marketplace. The company has intensified its industry presence through strategic acquisitions, such as the definitive agreement to acquire Upfront Healthcare Services, a next-generation patient engagement platform. This acquisition is anticipated to close in early 2025^4. Alongside this, Health Catalyst has secured strategic partnerships, like the multi-year alliance with OrthoNebraska, demonstrating its commitment to advancing healthcare analytics and patient outcomes.
In recent news, the company has made technological strides by releasing 10 AI-integrated data toolkits on the Databricks Marketplace. These toolkits aim to tackle pressing healthcare challenges and provide solutions that promise actionable insights^5. This move underscores Health Catalyst’s positioning itself as a transformative force within the healthcare industry, fueled by strategic outreach and innovation.
Further reflecting the company’s market progression, Health Catalyst's Ignite™ platform is cited as a pivotal growth driver, fostering strong revenue growth and indicating improved financial prospects. This platform is instrumental in Health Catalyst’s ability to expand its service offerings and enhance operational efficiency, positioning it as a frontrunner in the competitive healthcare data analytics arena^6.
The company’s ambition is not only reflected in its market activity but also with analyst upgrades. Recently, Zacks Investment firm upgraded Health Catalyst to a "Buy" status, marking growing optimism about its prospective earnings and positioning in the healthcare sector^7.
Health Catalyst’s stock, listed under NASDAQ as HCAT, was recently priced at $4.06, experiencing modest fluctuations with potential for growth reinforced by internal and market advancements. While the company’s financial performance faces scrutiny, there remains a strategic underpinning that could transform its market performance over time^8.
In navigating its market, Health Catalyst’s executive compensation stands as a testament to its commitment to align executive motivations with strategic growth and stakeholder value, integral to its operational ethos and long-term vision.
---
1. SEC Archive, [Linda Llewelyn 2024 Compensation](https://www.sec.gov/Archives/edgar/data/1636422/000163642225000075/0001636422-25-000075-index.htm).
2. SEC Archive, [Bryan Hunt 2023 Compensation](https://www.sec.gov/Archives/edgar/data/1636422/000163642224000058/0001636422-24-000058-index.htm).
3. SEC Archive, [Daniel Orenstein 2020 Compensation](https://www.sec.gov/Archives/edgar/data/1636422/000163642222000017/0001636422-22-000017-index.htm).
4. PRNewswire, [Health Catalyst Acquisition of Upfront Healthcare Services](https://www.prnewswire.com/news-releases/health-catalyst-signs-definitive-agreement-to-acquire-upfront-healthcare-services-301219711.html).
5. PRNewswire, [Health Catalyst Data Toolkits Announcement](https://www.prnewswire.com/news-releases/accelerating-measurable-improvement-through-actionable-insights-health-catalyst-announces-the-release-of-10-ai-integrated-data-toolkits-on-databricks-marketplace-302495087.html).
6. Seeking Alpha, [Health Catalyst Ignite Platform](https://seekingalpha.com/article/4793859-health-catalyst-ignite-platform-is-a-growth-catalyst).
7. Zacks, [Health Catalyst Upgraded to Buy](https://www.zacks.com/stock/news/2515555/health-catalyst-hcat-upgraded-to-buy-here-s-why?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape%7Cyseop_template_12_zacks_rank_upgrade-2515555).
8. Market Data, [Health Catalyst Stock Snapshot](https://www.nasdaq.com/market-activity/stocks/hcat).
